In a move that could majorly shift access and affordability of weight loss medications, the Biden administration has proposed that Medicare and Medicaid should begin covering drugs like Wegovy, Ozempic, and Mounjaro. Previously, coverage has been limited, with these medications only being insured when used to treat conditions like diabetes. As reported by NBC News, this policy change would extend benefits to an additional 3.4 million Medicare users and around 4 million Medicaid enrollees.
Meanwhile, consumers are navigating a murky landscape as the demand for weight loss drugs is on the rise. With insurance often not covering brand-name medications that can cost upwards of $1,500 a month, many are seeking out cheaper alternatives. However, the ABC7 Chicago I-Team's investigation in collaboration with ABC News found that purchasing drugs online can be perilous—a sobering reminder when one considers that six of 11 samples from various websites contained percentiles of the active ingredient that deviated from acceptable industry standards. Terrifyingly none of the samples had any of the active ingredients listed, and quantities in others were wildly inconsistent, some containing more than 250 times the listed potency. The affair is detailed by ABC7 Chicago.
For those seeking alternative avenues, options like compounded drugs—analogous to popular commercial medications—are becoming a safe haven, provided they're obtained from licensed compounding pharmacies. One success story mentioned by ABC7 Chicago involves Amaria Cage, who reported saving $1,000 a month and losing 40 pounds in a year and a half through a local med spa, where she gets screened and the drug is administered by medical professionals. These establishments claim to provide a screened, safer experience compared to the online wild west.
"If you go to your doctor and they can write a prescription, if your insurance is going to pay for it, that's great. But, we're an alternative to that. We screen you; we take your blood pressure, your labs, and make sure you're a good candidate. You're consented; you're cleared," said Therese Murray, a practice manager and nurse. But still, the stakes couldn't be higher, with missteps potentially leading to life-threatening situations, as highlighted by the case of Chicagoan Mike Benson. In a statement obtained by ABC7 Chicago, Benson recounted his near-death experience after self-administering what he believed was Ozempic, only to learn it was actually insulin, sending him into a diabetic coma.
The push for expanded coverage and the cautionary tales of online purchases come against the backdrop of a healthcare system grappling with obesity, a risk factor for numerous chronic diseases. More than 40% of Americans are considered obese, according to the Centers for Disease Control and Prevention, putting them at higher risk for conditions such as heart disease and diabetes. Providing wider access to weight loss drugs through Medicare and Medicaid could begin to address not only health concerns but also socioeconomic and racial disparities in who receives these medications, as reported by NBC News.
